Citi & Leerink Swann Upgrade Bristol-Myers (BMY) to Buy/Outperform
Tweet Send to a Friend
Citi upgrades Bristol-Myers (NYSE: BMY) from Hold to Buy. PT increased from $28 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
